Clinical Trial Update: A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating how apitegromab works in subjects under 2 years old with spinal muscular atrophy (SMA). The study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy
• Spinal Muscular Atrophy Type

Drugs mentioned

• Apitegromab (SRK-015)

Snippet

Sponsor: Scholar Rock, Inc. | Conditions: Spinal Muscular Atrophy, SMA | Phase 2 | Status: RECRUITING